Your browser doesn't support javascript.
loading
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting.
Magee, Kara; Marsh, Ian R; Turek, Michelle M; Grudzinski, Joseph; Aluicio-Sarduy, Eduardo; Engle, Jonathan W; Kurzman, Ilene D; Zuleger, Cindy L; Oseid, Elizabeth A; Jaskowiak, Christine; Albertini, Mark R; Esbona, Karla; Bednarz, Bryan; Sondel, Paul M; Weichert, Jamey P; Morris, Zachary S; Hernandez, Reinier; Vail, David M.
Afiliação
  • Magee K; Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Marsh IR; Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Turek MM; Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Grudzinski J; Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Aluicio-Sarduy E; Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Engle JW; Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Kurzman ID; Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Zuleger CL; Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Oseid EA; Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Jaskowiak C; Office of Environment, Health and Safety, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Albertini MR; Department of Radiology, School of Medicine and Public Health, Madison, Wisconsin, United States of America.
  • Esbona K; Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Bednarz B; Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Sondel PM; The Medical Service, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, United States of America.
  • Weichert JP; Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, Madison, Wisconsin, United States of America.
  • Morris ZS; Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
  • Hernandez R; Department of Radiology, School of Medicine and Public Health, Madison, Wisconsin, United States of America.
  • Vail DM; Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
PLoS One ; 16(8): e0255798, 2021.
Article em En | MEDLINE | ID: mdl-34383787
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteossarcoma / Interleucina-2 / Compostos Radiofarmacêuticos / Melanoma / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteossarcoma / Interleucina-2 / Compostos Radiofarmacêuticos / Melanoma / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article